Monitoring oral anticoagulation therapy.
Although VKAs are often criticised for the need of frequent monitoring, such a practice is very beneficial. Recommended 12-weekly monitoring, rather than 4-weekly, in patients with consistently stable INRs may help reduce patient inconvenience. The recommended use of patient self-management of anticoagulation in motivated and competent patients is further very helpful. In the absence of laboratory test and antidotes to reverse their effects, the use of NOACs is quite challenging.